Actinium Pharmaceuticals Inc (ATNM) — Capital Reinvestment Ratio
Actinium Pharmaceuticals Inc (ATNM) has a Capital Reinvestment Ratio of 0.01x as of June 2022, meaning it reinvests 0% of its operating cash flow ($27.92 Million) in capital expenditures ($270.00K). Check Actinium Pharmaceuticals Inc (ATNM) tangible equity ratio to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Actinium Pharmaceuticals Inc Capital Reinvestment Ratio (2022–2022)
This chart tracks Actinium Pharmaceuticals Inc's Capital Reinvestment Ratio across 1 annual periods. For the full cash flow conversion analysis, see ATNM operating cash flow.
Annual Capital Reinvestment Ratio for Actinium Pharmaceuticals Inc (2022–2022)
Year-by-year Capital Reinvestment Ratio for Actinium Pharmaceuticals Inc from 2022 to 2022. See Actinium Pharmaceuticals Inc (ATNM) FCF generation index to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2022 | 0.04x | $8.64 Million | $366.00K | — |